Skip to content
StockMarketAgent
Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

ETR/1AE stock hub

ETR/1AE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

ETR/1AEis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
41.7B
Deutsche Börse Xetra
Market data

Live price

Current market quote for this ticker.

Current price
ETR/1AE
In the news

Latest news · ETR/1AE

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E25
P25 n/aP50 n/aP75 n/a
Trailing P/E32.3
P25 n/aP50 n/aP75 n/a
ROEn/a
P25 n/aP50 n/aP75 n/a
ROIC44.3
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All ETR/1AE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
140
Groups with data
10
Currency
USD
Showing 140 of 140 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
Netherlands
Country code
DE
Employees
1,863
Employees Change
264%
Employees Change Percent
16.51
Enterprise value
EUR 37.9B
Exchange
Deutsche Börse Xetra
Financial currency
USD
First seen
2026-05-10
Industry
Biological Products, Except Diagnostic Substances
Last refreshed
2026-05-10
Market cap
EUR 41.7B
Price
EUR 670
Price currency
EUR
Rev Per Employee
2,207,806.42x
Sic
2836
Symbol
etr/1AE
Website
https://argenx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

9
MetricValue
Earnings Yield
3.1%
EV Earnings
29.35x
EV/EBIT
33.69x
EV/EBITDA
33.2x
EV/Sales
9.22x
Forward P/E
25.02x
P/B ratio
6.57x
P/E ratio
32.3x
P/S ratio
10.14x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

15
MetricValue
EBIT Margin
27.61%
EBITDA Margin
27.8%
Gross margin
58.11%
Gross Profit
EUR 2.4B
Gross Profit Growth
110.26%
Gross Profit Growth Q
79.4%
Net Income
EUR 1.3B
Net Income Growth
39.93%
Net Income Growth Q
115.97%
Pretax Margin
31.68%
Profit Margin
31.4%
Profit Per Employee
EUR 693,205
Roa5y
-4.42
Roe5y
-3.39
ROIC
44.29

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

6
MetricValue
EPS Growth
41.13
EPS Growth Q
114
Revenue Growth
79.43x
Revenue Growth Q
62.63x
Revenue Growth3 Y
95.02x
Revenue Growth5 Y
87.32x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

13
MetricValue
Cash
EUR 3.9B
Debt
EUR 40.9M
Debt EBITDA
EUR 0.04
Debt Equity
EUR 0.01
Equity
EUR 6.4B
Interest Coverage
412.5
Net Cash
EUR 3.8B
Net Cash By Market Cap
EUR 9.13
Net Cash Growth
31.53%
Net Debt EBITDA
EUR -3.33
Net Debt Equity
EUR -0.6
Tangible Book Value
EUR 6.1B
Tangible Book Value Per Share
EUR 98.82

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
0.85%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

28
MetricValue
50-day SMA
652.4
All Time High
806
All Time High Change
-16.87%
All Time High Date
2025-11-20
All Time Low
574.2
All Time Low Change
16.68%
All Time Low Date
2026-03-23
ATR
15.66
Ch YTD
-6.42
High
670.4
High52
806
High52 Date
2025-11-20
High52ch
-16.87%
Low
665.4
Low52
574.2
Low52 Date
2026-03-23
Low52ch
16.68%
Ma50ch
2.7%
RSI
49.64
RSI Monthly
0
RSI Weekly
50.42
Sharpe ratio
0.18x
Sortino ratio
0.48
Total Return
0.85%
Tr YTD
-6.42
Tr1m
3.17%
Tr1w
-2.13%
Tr3m
-3.82%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

4
MetricValue
Operating Income
EUR 1.1B
Operating Income Growth
509
Operating Income Growth Q
178.9
Operating margin
27.61

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

5
MetricValue
Float
62,086,042%
Shares Insiders
0.16%
Shares Institutions
74.66%
Shares Qo Q
-0.11%
Shares Yo Y
-0.85%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

41
MetricValue
Average Volume
91.8x
Bv Per Share
102.6
Ch1m
3.17
Ch1w
-2.13
Ch3m
-3.82
Ch6m
-8.22
Change
-0.27%
Change From Open
0.18
Close
671.8
Days Gap
-0.45
Depreciation Amortization
7,356,282.3
Dollar Volume
197,650
Earnings Date
2026-05-07
EBIT
EUR 1.1B
EBITDA
EUR 1.1B
EPS
EUR 19.51
F Score
2
Fiscal Year End
December
Founded
2,008
Graham Number
218.19112
Graham Upside
-67.43
Income Tax
EUR 11.8M
Is Primary Listing
0
Last Earnings Date
2026-05-07
Last Report Date
2026-03-31
Ma150
696.9
Ma150ch
-3.86%
Ma20
684.3
Ma20ch
-2.09%
Next Earnings Date
2026-07-23
Open
668.8
Position In Range
92
Price Date
2026-05-08
Price EBITDA
EUR 36.49
Ptbv Ratio
6.82
Relative Volume
3.21x
Revenue
4,113,143,364x
Tax By Revenue
0.29x
Tax Rate
0.9%
Tr6m
-8.22%
Volume
295
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does ETR/1AE pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns ETR/1AE?

Insider, institutional, and short-interest positioning.

Institutional ownership
+74.7%
Share of float held by funds and institutions
Insider ownership
+0.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-0.8%
Negative means the company is buying back shares.
Technical

ETR/1AE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
49.6
Neutral momentum band
Price vs 200-day MA
n/a
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.18
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About ETR/1AE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/1AE stock rating?

etr/1AE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/1AE analysis?

The full report lives at /stocks/etr/1AE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/1AE?

The latest report frames etr/1AE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/1AE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.